Patents by Inventor Steven Gendreau

Steven Gendreau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190083646
    Abstract: The emergence of mutations in tyrosine kinases following treatment of cancer patients with molecular-targeted therapy represents a major mechanism of acquired drug resistance. Here, mutations in the serpentine receptor, Smoothened (SMO) are described, which result in resistance to a Hedgehog (Hh) pathway inhibitor, such as in medulloblastoma. Amino acid substitutions in conserved residues of SMO maintain Hh signaling, but result in the inability of the Hh pathway inhibitor, GDC-0449, to suppress the pathway. In some embodiments, the disclosure provides for novel mutant SMO proteins and nucleic acids and for screening methods to detect SMO mutations and methods to screen for drugs that specifically modulate mutant SMO exhibiting drug resistance.
    Type: Application
    Filed: August 3, 2018
    Publication date: March 21, 2019
    Applicants: CURIS, INC., GENENTECH, INC.
    Inventors: Hayley SHARPE, Steven GENDREAU
  • Publication number: 20070141649
    Abstract: Human LOC169505 genes are identified as modulators of the APC and axin pathways, and thus are therapeutic targets for disorders associated with defective APC and axin function. Methods for identifying modulators of APC and axin, comprising screening for agents that modulate the activity of LOC169505 are provided.
    Type: Application
    Filed: November 24, 2003
    Publication date: June 21, 2007
    Applicant: Exelixis, Inc.
    Inventors: Steven Gendreau, Eva Mora-Blanco, Lynn Bjerke
  • Publication number: 20070141648
    Abstract: Human FLJ10607 genes are identified as modulators of the Axin pathway, and thus are therapeutic targets for disorders associated with defective Axin function. Methods for identifying modulators of Axin, comprising screening for agents that modulate the activity of FLJ10607 are provided.
    Type: Application
    Filed: December 29, 2003
    Publication date: June 21, 2007
    Inventors: Steven Gendreau, Emery Dora, Kim Lickteig
  • Publication number: 20060265763
    Abstract: Human DYRK genes are identified as modulators of the APC and Axin pathways, and thus are therapeutic targets for disorders associated with defective APC and Axin function. Methods for identifying modulators of APC and Axin, comprising screening for agents that modulate the activity of DYRK are provided.
    Type: Application
    Filed: February 10, 2004
    Publication date: November 23, 2006
    Applicant: EXELIXIS, INC.
    Inventors: Steven Gendreau, Eva Morablanco, Timothy Hauer, Kim Lickteig
  • Publication number: 20060157380
    Abstract: A post in post structure comprising a short inner post segment and a pair of hollow outer posts slipped over either end of the inner post segment and affixed to the inner post segment. The post in post structure is particularly suitable for use with a product packaging and display system of the kind having vertically spaced trays supported by outer posts 16 located over openings in each tray and inner posts inserted inside the outer support posts and through the tray openings to lock the system together.
    Type: Application
    Filed: January 19, 2005
    Publication date: July 20, 2006
    Applicant: SONOCO DEVELOPMENT, INC.
    Inventors: James LOWRY, Steven Gendreau, Lawrence RENCK
  • Publication number: 20050176013
    Abstract: Human PAPSS genes are identified as modulators of the AXIN pathway, and thus are therapeutic targets for disorders associated with defective AXIN function. Methods for identifying modulators of AXIN, comprising screening for agents that modulate the activity of PAPSS are provided.
    Type: Application
    Filed: August 6, 2003
    Publication date: August 11, 2005
    Inventors: Steven Gendreau, Emery Dora, Kim Lickteig